Skip to main content

Month: August 2022

Quisitive Reports Second Quarter 2022 Financial Results

TORONTO, Aug. 18, 2022 (GLOBE NEWSWIRE) — Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS, OTCQX: QUISF), a premier Microsoft solutions and payment solutions provider, today reported financial results for the second quarter ended June 30, 2022. Management Commentary“We’ve successfully achieved another record mark for top line revenue and Adjusted EBITDA with strong contributions from both our payments and cloud solutions segments, highlighting the efficacy of our dual business model,” said Quisitive CEO Mike Reinhart. “The continued success of the cloud business was centered on ramping up cross-sell and upsell opportunities since the Catapult acquisition to build upon our momentum in capturing significant share in the growing global cloud market. In parallel, we experienced and took...

Continue reading

Manufactured Housing Properties Inc. Announces Results for the Three and Six Months Ended June 30, 2022

Revenues and Adjusted EBITDA Increased 83% and 30%, respectively Over Prior Period For the Six Months Ended June 30, 2022 CHARLOTTE, N.C., Aug. 18, 2022 (GLOBE NEWSWIRE) — Manufactured Housing Properties Inc. (OTC: MHPC), which acquires, owns, and operates 49 manufactured housing communities containing approximately 2,350 developed sites, today announced operating results for the quarter ended June 30, 2022. Total revenues and adjusted EBITDA for the quarter ended June 30, 2022 were $3,371,371 and $725,798, respectively, compared to $1,799,438 and $840,719, respectively for the quarter ended June 30, 2021. Total revenues and adjusted EBITDA for the six months ended June 30, 2022 were $6,426,393 and $1,797,505, respectively, compared to $3,505,302 and $1,385,874, respectively for the six months ended June 30, 2021. Jay Wardlaw,...

Continue reading

Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total prescription growth for JATENZO® increased 23% sequentially and increased 72% year-over-year Immediate reduction in workforce by approximately 40% of total headcount; transition of Chief Financial Officer role NORTHBROOK, Ill., Aug. 18, 2022 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies, today reported financial results for the second quarter of 2022. Clarus also announced that it is pursuing an immediate reduction in staff as it evaluates strategic alternatives and terminates certain research and development activities. “Although Clarus delivered another quarter of steady...

Continue reading

StoneCo Reports Second Quarter 2022 Results

Revenue growth of 275.6% year over year in 2Q22 (82.8% ex-credit and pro-forma for Linx) to R$2.30 billion, 4.7% above the upper end of our guidance; Adj. EBT (not adjusting for bond expenses) of R$106.7 million, above guidance of +R$90 million; MSMB take rate improvement to 2.09% in 2Q22 from 2.06% in 1Q22 GEORGE TOWN, Grand Cayman, Aug. 18, 2022 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”), a leading provider of financial technology and software solutions that empowers merchants to conduct commerce seamlessly across multiple channels, today reports its financial results for its second quarter ended June 30, 2022. “Dear Shareholders, I believe our strong second quarter results continue to reinforce our recovery and we are seeing a more consistent pattern of performance so far in the first half of...

Continue reading

Navigator Holdings Ltd. Results for the Three and Six Months Ended June 30, 2022

HighlightsNavigator Holdings Ltd. (the “Company”) reported total operating revenues of $123.9 million for the three months ended June 30, 2022, an increase from $85.7 million for the three months ended June 30, 2021. Total operating revenues were $243.7 million for the six months ended June 30, 2022, an increase from $171.4 million for the six ended June 30, 2021. Net income was $14.0 million (earnings per share of $0.18) for the three months ended June 30, 2022, an increase from $0.3 million (earnings per share of $0.01) for the three months ended June 30, 2021. For the six months ended June 30, 2022, net income was $41.1 million (earnings per share of $0.53) compared to $3.1 million (earnings per share of $0.06) for the six months ended June 30, 2021. EBITDA1 was $55.0 million for the three months ended June 30, 2022 compared to $28.8...

Continue reading

Applied Materials Announces Third Quarter 2022 Results

Record quarterly revenue of $6.52 billion, up 5 percent year over year GAAP EPS of $1.85 and non-GAAP EPS of $1.94, down 1 percent and up 2 percent year over year, respectively Generated $1.47 billion in cash from operations and returned $1.23 billion to shareholdersSANTA CLARA, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) — Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its third quarter ended Jul. 31, 2022. Third Quarter Results Applied generated revenue of $6.52 billion. On a GAAP basis, the company achieved gross margin of 46.1 percent, operating income of $1.92 billion or 29.5 percent of net sales, and earnings per share (EPS) of $1.85. On a non-GAAP adjusted basis, the company reported gross margin of 46.2 percent, operating income of $1.95 billion or 30.0 percent of net sales, and EPS of $1.94. The company...

Continue reading

Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

ARLINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA) (“Kala” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.001 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on August 29, 2022. The shares of Series D Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on August 30, 2022. The outstanding shares of Series D Preferred Stock will vote together with the outstanding shares of the Company’s common stock, as a single class,...

Continue reading

WestBond Increases Sales and Profits for the Quarter ended June 30, 2022 and Announces Quarterly Dividend

DELTA, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) has posted a profit of $415,352 ($0.012 per share) for the three months ended June 30, 2022, compared to a profit of $69,688 ($0.002 per share) for the same period last year. Sales were $3,321,418 for the three months ended June 30, 2022, which is 22.6% higher than for the three months ended June 30, 2021 and 16.8% higher than for the three months ended March 31, 2022. Despite the supply-chain and labour challenges faced in our industry, our sales and profits have improved significantly when compared with the same period last year and in the previous quarter. We are pleased to declare a quarterly dividend of $0.005 per share which will be paid on September 23, 2022 to shareholders of record on September 5, 2022. The dividends...

Continue reading

Reunion Gold Strengthens Its Board and Management Team With the Appointment of a New Director and a VP Exploration

LONGUEUIL, Quebec, Aug. 18, 2022 (GLOBE NEWSWIRE) — Reunion Gold Corporation (TSXV: RGD; OTCQB: RGDFF) (the “Company”) is pleased to announce the appointment of Fred Stanford as Director and Justin van der Toorn as Vice President, Exploration. The appointments reflect the ongoing exploration success at Reunion Gold’s Oko West project in Guyana and the Company’s desire to aggressively advance this exciting discovery. Fred Stanford brings a long track record of success as an executive in the mining industry and skill sets that will be invaluable to both the Board and management team in advancing Oko West and the overall strategy of Reunion Gold. Justin van der Toorn will work closely with Interim CEO Carlos Bertoni and the Oko West exploration team to continue advancing the Oko West exploration programs. He will also be responsible...

Continue reading

Save Foods, Inc. Announces Closing of Public Offering

Neve Yarak, Israel, Aug. 18, 2022 (GLOBE NEWSWIRE) — Save Foods, Inc. (Nasdaq: SVFD) (FSE:80W), an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, today announced the closing of its previously announced public offering of 1,600,000 shares of its common stock at a public offering price of $3.00 per share, for gross proceeds of $4.8 million, before deducting underwriting discounts and offering expenses. In addition, Save Foods, Inc. has granted the underwriters a 45-day option to purchase up to an additional 240,000 shares of common stock to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions. The Company intends to use the proceeds from the offering for working capital and general...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.